NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas

por Górka, B, Skubis-Zegadło, J, Mikula, M, Bardadin, K, Paliczka, E, Czarnocka, B
Publicado 2007

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

por Pitkin, L, Luangdilok, S, Corbishley, C, Wilson, P O G, Dalton, P, Bray, D, Mady, S, Williamson, P, Odutoye, T, Rhys Evans, P, Syrigos, K N, Nutting, C M, Barbachano, Y, Eccles, S, Harrington, K J
Publicado 2007

MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden

por Andrén, O, Fall, K, Andersson, S-O, Rubin, M A, Bismar, T A, Karlsson, M, Johansson, J-E, Mucci, L A
Publicado 2007

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo

por Mellor, P, Harvey, J R, Murphy, K J, Pye, D, O'Boyle, G, Lennard, T W J, Kirby, J A, Ali, S
Publicado 2007

Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts

por Vlahovic, G, Ponce, A M, Rabbani, Z, Salahuddin, F K, Zgonjanin, L, Spasojevic, I, Vujaskovic, Z, Dewhirst, M W
Publicado 2007

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer

por Torrisi, R, Bagnardi, V, Pruneri, G, Ghisini, R, Bottiglieri, L, Magni, E, Veronesi, P, D'Alessandro, C, Luini, A, Dellapasqua, S, Viale, G, Goldhirsch, A, Colleoni, M
Publicado 2007

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

por Agalliu, I, Karlins, E, Kwon, E M, Iwasaki, L M, Diamond, A, Ostrander, E A, Stanford, J L
Publicado 2007

Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences

por Pieterse, A H, Stiggelbout, A M, Baas-Thijssen, M C M, van de Velde, C J H, Marijnen, C A M
Publicado 2007

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2007

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

por Boige, V, Raoul, J-L, Pignon, J-P, Bouché, O, Blanc, J-F, Dahan, L, Jouve, J-L, Dupouy, N, Ducreux, M
Publicado 2007

Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer

por Nonomura, N, Takayama, H, Nishimura, K, Oka, D, Nakai, Y, Shiba, M, Tsujimura, A, Nakayama, M, Aozasa, K, Okuyama, A
Publicado 2007

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

por Cheng, Y Y, Yu, J, Wong, Y P, Man, E P S, To, K F, Jin, V X, Li, J, Tao, Q, Sung, J J Y, Chan, F K L, Leung, W K
Publicado 2007

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein

por Mi, Y, Lou, L
Publicado 2007

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel

por Martinelli, M, Bonezzi, K, Riccardi, E, Kuhn, E, Frapolli, R, Zucchetti, M, Ryan, A J, Taraboletti, G, Giavazzi, R
Publicado 2007

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

por González, L O, Pidal, I, Junquera, S, Corte, M D, Vázquez, J, Rodríguez, J C, Lamelas, M L, Merino, A M, García-Muñiz, J L, Vizoso, F J
Publicado 2007

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia

por Lee, C-Y, Tien, H-F, Hu, C-Y, Chou, W-C, Lin, L-I
Publicado 2007

Increased Dickkopf-1 expression in breast cancer bone metastases

por Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, J J, Clézardin, P, Garnero, P
Publicado 2007

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

por Frattini, M, Saletti, P, Romagnani, E, Martin, V, Molinari, F, Ghisletta, M, Camponovo, A, Etienne, L L, Cavalli, F, Mazzucchelli, L
Publicado 2007

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases

por Barone, C, Nuzzo, G, Cassano, A, Basso, M, Schinzari, G, Giuliante, F, D'Argento, E, Trigila, N, Astone, A, Pozzo, C
Publicado 2007

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

por Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J
Publicado 2007